z-logo
open-access-imgOpen Access
Therapeutic Effects of Hydrogen-Rich Solution on Aplastic Anemia in Vivo
Author(s) -
Sanhu Zhao,
Ke Mei,
Liren Qian,
Yanyong Yang,
Wen Liu,
Yijuan Huang,
Chao Zhang,
Xue Sun,
Cong Liu,
Bailong Li,
Fu Gao,
Jianming Cai,
Ni Jin
Publication year - 2013
Publication title -
cellular physiology and biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.486
H-Index - 87
eISSN - 1421-9778
pISSN - 1015-8987
DOI - 10.1159/000354459
Subject(s) - bone marrow , in vivo , haematopoiesis , cytokine , tumor necrosis factor alpha , medicine , aplastic anemia , immunology , immune system , bone marrow failure , transplantation , cd8 , cancer research , stem cell , biology , microbiology and biotechnology
Aplasitc anemia (AA) is a bone marrow failure syndrome characterized by an immune-mediated destruction of hematopoietic stem cells. Though clinical symptoms could be ameliorated by bone marrow transplantation and/or immunosuppressive therapy, frequent recurrence and especially evolution of clonal hematologic diseases remains problematic clinically. Cytokines such as interferon-γ (INF-γ), tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) secreted by autologous T cells are closely related with the development of AA. Hydrogen-rich solution was reported to inhibit the levels of cytokines including INF-γ, TNF-α and IL-6 in vivo in recent studies. This study was to investigate the potential therapeutic effects of hydrogen-rich solution on AA in vivo.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom